CD8A and neoplasm: Further, targeting of SLAMF7 on CD8+ T cells could serve as a mean to regulate the formation of ICAM-1-LFA-1 dependent CTL populations within the tumor tissue [54], and by enrichment of tumor-specific CD8+ T cells, SLAMF7 signals could improve the tumor control.